ProQR Therapeutics
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does ProQR Therapeutics use?+
ProQR Therapeutics uses 11 technologies including Drupal, Google Analytics, Google Tag Manager.
What industry is ProQR Therapeutics in?+
ProQR Therapeutics operates in the Biotechnology industry.
Where is ProQR Therapeutics based?+
ProQR Therapeutics is headquartered in Thailand.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026